ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder	Active, not recruiting	Early phase 1	2026-06-22		NCT05056896

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Massachusetts General Hospital	758
National Cancer Institute (NCI)	3015
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
National Institutes of Health (NIH)	667

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Massachusetts General Hospital Cancer Center	Boston	United States	178